Summary
Women who’ve been recently diagnosed with breast cancer are almost immediately faced with treatment choices. The most common options are to remove the cancerous tissue in part of the breast (lumpectomy) or to remove the entire breast (mastectomy).
A lumpectomy is a form of breast-conserving and preservation surgery used for the removal of breast tumor or some surrounding tissues. It is also known as a partial mastectomy because a part of breast tissue is removed in this procedure, whereas in mastectomy, the full breast is removed to avoid chances of cancer development in future.
According to APO Research, The global Breast-Conserving Surgery market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Breast-Conserving Surgery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Breast-Conserving Surgery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Breast-Conserving Surgery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Breast-Conserving Surgery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Breast-Conserving Surgery include Hologic, BD, Danaher, Carl Zeiss Meditech, Merit Medical, Argon Medical Devices, Sanarus, Endomagnetics and SOMATEX Medical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Breast-Conserving Surgery, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Breast-Conserving Surgery, also provides the revenue of main regions and countries. Of the upcoming market potential for Breast-Conserving Surgery, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Breast-Conserving Surgery revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Breast-Conserving Surgery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Breast-Conserving Surgery revenue, projected growth trends, production technology, application and end-user industry.
Breast-Conserving Surgery segment by Company
Hologic
BD
Danaher
Carl Zeiss Meditech
Merit Medical
Argon Medical Devices
Sanarus
Endomagnetics
SOMATEX Medical
Ranfac
STERYLAB
Breast-Conserving Surgery segment by Type
Lumpectomy Systems
Lumpectomy Surgical Tools
Breast-Conserving Surgery segment by Application
Hospitals
Ambulatory Surgical Centers
Breast-Conserving Surgery segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breast-Conserving Surgery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Breast-Conserving Surgery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breast-Conserving Surgery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Breast-Conserving Surgery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Breast-Conserving Surgery company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Breast-Conserving Surgery revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Breast-Conserving Surgery Market by Type
1.2.1 Global Breast-Conserving Surgery Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Lumpectomy Systems
1.2.3 Lumpectomy Surgical Tools
1.3 Breast-Conserving Surgery Market by Application
1.3.1 Global Breast-Conserving Surgery Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Breast-Conserving Surgery Market Dynamics
2.1 Breast-Conserving Surgery Industry Trends
2.2 Breast-Conserving Surgery Industry Drivers
2.3 Breast-Conserving Surgery Industry Opportunities and Challenges
2.4 Breast-Conserving Surgery Industry Restraints
3 Global Growth Perspective
3.1 Global Breast-Conserving Surgery Market Perspective (2019-2030)
3.2 Global Breast-Conserving Surgery Growth Trends by Region
3.2.1 Global Breast-Conserving Surgery Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Breast-Conserving Surgery Market Size by Region (2019-2024)
3.2.3 Global Breast-Conserving Surgery Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Breast-Conserving Surgery Revenue by Players
4.1.1 Global Breast-Conserving Surgery Revenue by Players (2019-2024)
4.1.2 Global Breast-Conserving Surgery Revenue Market Share by Players (2019-2024)
4.1.3 Global Breast-Conserving Surgery Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Breast-Conserving Surgery Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Breast-Conserving Surgery Key Players Headquarters & Area Served
4.4 Global Breast-Conserving Surgery Players, Product Type & Application
4.5 Global Breast-Conserving Surgery Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Breast-Conserving Surgery Market CR5 and HHI
4.6.2 Global Top 5 and 10 Breast-Conserving Surgery Players Market Share by Revenue in 2023
4.6.3 2023 Breast-Conserving Surgery Tier 1, Tier 2, and Tier 3
5 Breast-Conserving Surgery Market Size by Type
5.1 Global Breast-Conserving Surgery Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Breast-Conserving Surgery Revenue by Type (2019-2030)
5.3 Global Breast-Conserving Surgery Revenue Market Share by Type (2019-2030)
6 Breast-Conserving Surgery Market Size by Application
6.1 Global Breast-Conserving Surgery Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Breast-Conserving Surgery Revenue by Application (2019-2030)
6.3 Global Breast-Conserving Surgery Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Hologic
7.1.1 Hologic Comapny Information
7.1.2 Hologic Business Overview
7.1.3 Hologic Breast-Conserving Surgery Revenue and Gross Margin (2019-2024)
7.1.4 Hologic Breast-Conserving Surgery Product Portfolio
7.1.5 Hologic Recent Developments
7.2 BD
7.2.1 BD Comapny Information
7.2.2 BD Business Overview
7.2.3 BD Breast-Conserving Surgery Revenue and Gross Margin (2019-2024)
7.2.4 BD Breast-Conserving Surgery Product Portfolio
7.2.5 BD Recent Developments
7.3 Danaher
7.3.1 Danaher Comapny Information
7.3.2 Danaher Business Overview
7.3.3 Danaher Breast-Conserving Surgery Revenue and Gross Margin (2019-2024)
7.3.4 Danaher Breast-Conserving Surgery Product Portfolio
7.3.5 Danaher Recent Developments
7.4 Carl Zeiss Meditech
7.4.1 Carl Zeiss Meditech Comapny Information
7.4.2 Carl Zeiss Meditech Business Overview
7.4.3 Carl Zeiss Meditech Breast-Conserving Surgery Revenue and Gross Margin (2019-2024)
7.4.4 Carl Zeiss Meditech Breast-Conserving Surgery Product Portfolio
7.4.5 Carl Zeiss Meditech Recent Developments
7.5 Merit Medical
7.5.1 Merit Medical Comapny Information
7.5.2 Merit Medical Business Overview
7.5.3 Merit Medical Breast-Conserving Surgery Revenue and Gross Margin (2019-2024)
7.5.4 Merit Medical Breast-Conserving Surgery Product Portfolio
7.5.5 Merit Medical Recent Developments
7.6 Argon Medical Devices
7.6.1 Argon Medical Devices Comapny Information
7.6.2 Argon Medical Devices Business Overview
7.6.3 Argon Medical Devices Breast-Conserving Surgery Revenue and Gross Margin (2019-2024)
7.6.4 Argon Medical Devices Breast-Conserving Surgery Product Portfolio
7.6.5 Argon Medical Devices Recent Developments
7.7 Sanarus
7.7.1 Sanarus Comapny Information
7.7.2 Sanarus Business Overview
7.7.3 Sanarus Breast-Conserving Surgery Revenue and Gross Margin (2019-2024)
7.7.4 Sanarus Breast-Conserving Surgery Product Portfolio
7.7.5 Sanarus Recent Developments
7.8 Endomagnetics
7.8.1 Endomagnetics Comapny Information
7.8.2 Endomagnetics Business Overview
7.8.3 Endomagnetics Breast-Conserving Surgery Revenue and Gross Margin (2019-2024)
7.8.4 Endomagnetics Breast-Conserving Surgery Product Portfolio
7.8.5 Endomagnetics Recent Developments
7.9 SOMATEX Medical
7.9.1 SOMATEX Medical Comapny Information
7.9.2 SOMATEX Medical Business Overview
7.9.3 SOMATEX Medical Breast-Conserving Surgery Revenue and Gross Margin (2019-2024)
7.9.4 SOMATEX Medical Breast-Conserving Surgery Product Portfolio
7.9.5 SOMATEX Medical Recent Developments
7.10 Ranfac
7.10.1 Ranfac Comapny Information
7.10.2 Ranfac Business Overview
7.10.3 Ranfac Breast-Conserving Surgery Revenue and Gross Margin (2019-2024)
7.10.4 Ranfac Breast-Conserving Surgery Product Portfolio
7.10.5 Ranfac Recent Developments
7.11 STERYLAB
7.11.1 STERYLAB Comapny Information
7.11.2 STERYLAB Business Overview
7.11.3 STERYLAB Breast-Conserving Surgery Revenue and Gross Margin (2019-2024)
7.11.4 STERYLAB Breast-Conserving Surgery Product Portfolio
7.11.5 STERYLAB Recent Developments
8 North America
8.1 North America Breast-Conserving Surgery Revenue (2019-2030)
8.2 North America Breast-Conserving Surgery Revenue by Type (2019-2030)
8.2.1 North America Breast-Conserving Surgery Revenue by Type (2019-2024)
8.2.2 North America Breast-Conserving Surgery Revenue by Type (2025-2030)
8.3 North America Breast-Conserving Surgery Revenue Share by Type (2019-2030)
8.4 North America Breast-Conserving Surgery Revenue by Application (2019-2030)
8.4.1 North America Breast-Conserving Surgery Revenue by Application (2019-2024)
8.4.2 North America Breast-Conserving Surgery Revenue by Application (2025-2030)
8.5 North America Breast-Conserving Surgery Revenue Share by Application (2019-2030)
8.6 North America Breast-Conserving Surgery Revenue by Country
8.6.1 North America Breast-Conserving Surgery Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Breast-Conserving Surgery Revenue by Country (2019-2024)
8.6.3 North America Breast-Conserving Surgery Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Breast-Conserving Surgery Revenue (2019-2030)
9.2 Europe Breast-Conserving Surgery Revenue by Type (2019-2030)
9.2.1 Europe Breast-Conserving Surgery Revenue by Type (2019-2024)
9.2.2 Europe Breast-Conserving Surgery Revenue by Type (2025-2030)
9.3 Europe Breast-Conserving Surgery Revenue Share by Type (2019-2030)
9.4 Europe Breast-Conserving Surgery Revenue by Application (2019-2030)
9.4.1 Europe Breast-Conserving Surgery Revenue by Application (2019-2024)
9.4.2 Europe Breast-Conserving Surgery Revenue by Application (2025-2030)
9.5 Europe Breast-Conserving Surgery Revenue Share by Application (2019-2030)
9.6 Europe Breast-Conserving Surgery Revenue by Country
9.6.1 Europe Breast-Conserving Surgery Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Breast-Conserving Surgery Revenue by Country (2019-2024)
9.6.3 Europe Breast-Conserving Surgery Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Breast-Conserving Surgery Revenue (2019-2030)
10.2 China Breast-Conserving Surgery Revenue by Type (2019-2030)
10.2.1 China Breast-Conserving Surgery Revenue by Type (2019-2024)
10.2.2 China Breast-Conserving Surgery Revenue by Type (2025-2030)
10.3 China Breast-Conserving Surgery Revenue Share by Type (2019-2030)
10.4 China Breast-Conserving Surgery Revenue by Application (2019-2030)
10.4.1 China Breast-Conserving Surgery Revenue by Application (2019-2024)
10.4.2 China Breast-Conserving Surgery Revenue by Application (2025-2030)
10.5 China Breast-Conserving Surgery Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Breast-Conserving Surgery Revenue (2019-2030)
11.2 Asia Breast-Conserving Surgery Revenue by Type (2019-2030)
11.2.1 Asia Breast-Conserving Surgery Revenue by Type (2019-2024)
11.2.2 Asia Breast-Conserving Surgery Revenue by Type (2025-2030)
11.3 Asia Breast-Conserving Surgery Revenue Share by Type (2019-2030)
11.4 Asia Breast-Conserving Surgery Revenue by Application (2019-2030)
11.4.1 Asia Breast-Conserving Surgery Revenue by Application (2019-2024)
11.4.2 Asia Breast-Conserving Surgery Revenue by Application (2025-2030)
11.5 Asia Breast-Conserving Surgery Revenue Share by Application (2019-2030)
11.6 Asia Breast-Conserving Surgery Revenue by Country
11.6.1 Asia Breast-Conserving Surgery Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Breast-Conserving Surgery Revenue by Country (2019-2024)
11.6.3 Asia Breast-Conserving Surgery Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Breast-Conserving Surgery Revenue (2019-2030)
12.2 MEALA Breast-Conserving Surgery Revenue by Type (2019-2030)
12.2.1 MEALA Breast-Conserving Surgery Revenue by Type (2019-2024)
12.2.2 MEALA Breast-Conserving Surgery Revenue by Type (2025-2030)
12.3 MEALA Breast-Conserving Surgery Revenue Share by Type (2019-2030)
12.4 MEALA Breast-Conserving Surgery Revenue by Application (2019-2030)
12.4.1 MEALA Breast-Conserving Surgery Revenue by Application (2019-2024)
12.4.2 MEALA Breast-Conserving Surgery Revenue by Application (2025-2030)
12.5 MEALA Breast-Conserving Surgery Revenue Share by Application (2019-2030)
12.6 MEALA Breast-Conserving Surgery Revenue by Country
12.6.1 MEALA Breast-Conserving Surgery Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Breast-Conserving Surgery Revenue by Country (2019-2024)
12.6.3 MEALA Breast-Conserving Surgery Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Breast-Conserving Surgery Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Lumpectomy Systems Major Manufacturers
Table 2. Lumpectomy Surgical Tools Major Manufacturers
Table 3. Global Breast-Conserving Surgery Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 4. Hospitals Major Manufacturers
Table 5. Ambulatory Surgical Centers Major Manufacturers
Table 6. Breast-Conserving Surgery Industry Trends
Table 7. Breast-Conserving Surgery Industry Drivers
Table 8. Breast-Conserving Surgery Industry Opportunities and Challenges
Table 9. Breast-Conserving Surgery Industry Restraints
Table 10. Global Breast-Conserving Surgery Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Breast-Conserving Surgery Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Breast-Conserving Surgery Market Share by Region (2019-2024)
Table 13. Global Breast-Conserving Surgery Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Breast-Conserving Surgery Market Share by Region (2025-2030)
Table 15. Global Breast-Conserving Surgery Revenue by Players (US$ Million) & (2019-2024)
Table 16. Global Breast-Conserving Surgery Revenue Market Share by Players (2019-2024)
Table 17. Global Breast-Conserving Surgery Key Players Ranking, 2022 VS 2023 VS 2024
Table 18. Global Breast-Conserving Surgery Key Players Headquarters & Area Served
Table 19. Global Breast-Conserving Surgery Players, Product Type & Application
Table 20. Global Breast-Conserving Surgery Players Commercialization Time
Table 21. Global Players Market Concentration Ratio (CR5 and HHI)
Table 22. Global Breast-Conserving Surgery by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 23. Global Breast-Conserving Surgery Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Breast-Conserving Surgery Revenue by Type (2019-2024) & (US$ Million)
Table 25. Global Breast-Conserving Surgery Revenue by Type (2025-2030) & (US$ Million)
Table 26. Global Breast-Conserving Surgery Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 27. Global Breast-Conserving Surgery Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 28. Global Breast-Conserving Surgery Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Breast-Conserving Surgery Revenue by Application (2019-2024) & (US$ Million)
Table 30. Global Breast-Conserving Surgery Revenue by Application (2025-2030) & (US$ Million)
Table 31. Global Breast-Conserving Surgery Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 32. Global Breast-Conserving Surgery Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 33. Hologic Company Information
Table 34. Hologic Business Overview
Table 35. Hologic Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 36. Hologic Breast-Conserving Surgery Product Portfolio
Table 37. Hologic Recent Development
Table 38. BD Company Information
Table 39. BD Business Overview
Table 40. BD Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 41. BD Breast-Conserving Surgery Product Portfolio
Table 42. BD Recent Development
Table 43. Danaher Company Information
Table 44. Danaher Business Overview
Table 45. Danaher Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 46. Danaher Breast-Conserving Surgery Product Portfolio
Table 47. Danaher Recent Development
Table 48. Carl Zeiss Meditech Company Information
Table 49. Carl Zeiss Meditech Business Overview
Table 50. Carl Zeiss Meditech Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 51. Carl Zeiss Meditech Breast-Conserving Surgery Product Portfolio
Table 52. Carl Zeiss Meditech Recent Development
Table 53. Merit Medical Company Information
Table 54. Merit Medical Business Overview
Table 55. Merit Medical Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 56. Merit Medical Breast-Conserving Surgery Product Portfolio
Table 57. Merit Medical Recent Development
Table 58. Argon Medical Devices Company Information
Table 59. Argon Medical Devices Business Overview
Table 60. Argon Medical Devices Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 61. Argon Medical Devices Breast-Conserving Surgery Product Portfolio
Table 62. Argon Medical Devices Recent Development
Table 63. Sanarus Company Information
Table 64. Sanarus Business Overview
Table 65. Sanarus Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 66. Sanarus Breast-Conserving Surgery Product Portfolio
Table 67. Sanarus Recent Development
Table 68. Endomagnetics Company Information
Table 69. Endomagnetics Business Overview
Table 70. Endomagnetics Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 71. Endomagnetics Breast-Conserving Surgery Product Portfolio
Table 72. Endomagnetics Recent Development
Table 73. SOMATEX Medical Company Information
Table 74. SOMATEX Medical Business Overview
Table 75. SOMATEX Medical Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 76. SOMATEX Medical Breast-Conserving Surgery Product Portfolio
Table 77. SOMATEX Medical Recent Development
Table 78. Ranfac Company Information
Table 79. Ranfac Business Overview
Table 80. Ranfac Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 81. Ranfac Breast-Conserving Surgery Product Portfolio
Table 82. Ranfac Recent Development
Table 83. STERYLAB Company Information
Table 84. STERYLAB Business Overview
Table 85. STERYLAB Breast-Conserving Surgery Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)
Table 86. STERYLAB Breast-Conserving Surgery Product Portfolio
Table 87. STERYLAB Recent Development
Table 88. North America Breast-Conserving Surgery Revenue by Type (2019-2024) & (US$ Million)
Table 89. North America Breast-Conserving Surgery Revenue by Application (2019-2024) & (US$ Million)
Table 90. North America Breast-Conserving Surgery Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 91. North America Breast-Conserving Surgery Revenue by Country (2019-2024) & (US$ Million)
Table 92. North America Breast-Conserving Surgery Revenue by Country (2025-2030) & (US$ Million)
Table 93. Europe Breast-Conserving Surgery Revenue by Type (2019-2024) & (US$ Million)
Table 94. Europe Breast-Conserving Surgery Revenue by Application (2019-2024) & (US$ Million)
Table 95. Europe Breast-Conserving Surgery Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 96. Europe Breast-Conserving Surgery Revenue by Country (2019-2024) & (US$ Million)
Table 97. Europe Breast-Conserving Surgery Revenue by Country (2025-2030) & (US$ Million)
Table 98. China Breast-Conserving Surgery Revenue by Type (2019-2024) & (US$ Million)
Table 99. China Breast-Conserving Surgery Revenue by Application (2019-2024) & (US$ Million)
Table 100. Asia Breast-Conserving Surgery Revenue by Type (2019-2024) & (US$ Million)
Table 101. Asia Breast-Conserving Surgery Revenue by Application (2019-2024) & (US$ Million)
Table 102. Asia Breast-Conserving Surgery Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 103. Asia Breast-Conserving Surgery Revenue by Country (2019-2024) & (US$ Million)
Table 104. Asia Breast-Conserving Surgery Revenue by Country (2025-2030) & (US$ Million)
Table 105. MEALA Breast-Conserving Surgery Revenue by Type (2019-2024) & (US$ Million)
Table 106. MEALA Breast-Conserving Surgery Revenue by Application (2019-2024) & (US$ Million)
Table 107. MEALA Breast-Conserving Surgery Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 108. MEALA Breast-Conserving Surgery Revenue by Country (2019-2024) & (US$ Million)
Table 109. MEALA Breast-Conserving Surgery Revenue by Country (2025-2030) & (US$ Million)
Table 110. Research Programs/Design for This Report
Table 111. Authors List of This Report
Table 112. Secondary Sources
Table 113. Primary Sources
List of Figures
Figure 1. Breast-Conserving Surgery Product Picture
Figure 2. Global Breast-Conserving Surgery Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Breast-Conserving Surgery Market Size Share 2019 VS 2023 VS 2030
Figure 4. Lumpectomy Systems Picture
Figure 5. Lumpectomy Surgical Tools Picture
Figure 6. Global Breast-Conserving Surgery Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Breast-Conserving Surgery Market Size Share 2019 VS 2023 VS 2030
Figure 8. Hospitals Picture
Figure 9. Ambulatory Surgical Centers Picture
Figure 10. Global Breast-Conserving Surgery Market Size (US$ Million) & (2019-2030)
Figure 11. Global Breast-Conserving Surgery Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Breast-Conserving Surgery Market Share by Region: 2019 VS 2023 VS 2030
Figure 13. Global Breast-Conserving Surgery Players Revenue Share Top 10 and Top 5 in 2023
Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 15. Global Breast-Conserving Surgery Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Breast-Conserving Surgery Revenue Market Share 2019 VS 2023 VS 2030
Figure 17. Global Breast-Conserving Surgery Revenue Market Share by Type (2019-2030)
Figure 18. Global Breast-Conserving Surgery Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Breast-Conserving Surgery Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 20. Global Breast-Conserving Surgery Revenue Market Share by Application (2019-2030)
Figure 21. North America Breast-Conserving Surgery Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Breast-Conserving Surgery Revenue by Type (2025-2030) & (US$ Million)
Figure 23. North America Breast-Conserving Surgery Revenue Share by Type (2019-2030)
Figure 24. North America Breast-Conserving Surgery Revenue by Application (2025-2030) & (US$ Million)
Figure 25. North America Breast-Conserving Surgery Revenue Share by Application (2019-2030)
Figure 26. North America Breast-Conserving Surgery Revenue Share by Country (2019-2030)
Figure 27. United States Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 28. Canada Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Europe Breast-Conserving Surgery Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe Breast-Conserving Surgery Revenue by Type (2025-2030) & (US$ Million)
Figure 31. Europe Breast-Conserving Surgery Revenue Share by Type (2019-2030)
Figure 32. Europe Breast-Conserving Surgery Revenue by Application (2025-2030) & (US$ Million)
Figure 33. Europe Breast-Conserving Surgery Revenue Share by Application (2019-2030)
Figure 34. Europe Breast-Conserving Surgery Revenue Share by Country (2019-2030)
Figure 35. Germany Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 36. France Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. U.K. Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. Italy Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Russia Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Nordic Countries Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. China Breast-Conserving Surgery Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Breast-Conserving Surgery Revenue by Type (2025-2030) & (US$ Million)
Figure 43. China Breast-Conserving Surgery Revenue Share by Type (2019-2030)
Figure 44. China Breast-Conserving Surgery Revenue by Application (2025-2030) & (US$ Million)
Figure 45. China Breast-Conserving Surgery Revenue Share by Application (2019-2030)
Figure 46. Asia Breast-Conserving Surgery Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 47. Asia Breast-Conserving Surgery Revenue by Type (2025-2030) & (US$ Million)
Figure 48. Asia Breast-Conserving Surgery Revenue Share by Type (2019-2030)
Figure 49. Asia Breast-Conserving Surgery Revenue by Application (2025-2030) & (US$ Million)
Figure 50. Asia Breast-Conserving Surgery Revenue Share by Application (2019-2030)
Figure 51. Asia Breast-Conserving Surgery Revenue Share by Country (2019-2030)
Figure 52. Japan Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 53. South Korea Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. India Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. Australia Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. China Taiwan Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. Southeast Asia Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. MEALA Breast-Conserving Surgery Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 59. MEALA Breast-Conserving Surgery Revenue by Type (2025-2030) & (US$ Million)
Figure 60. MEALA Breast-Conserving Surgery Revenue Share by Type (2019-2030)
Figure 61. MEALA Breast-Conserving Surgery Revenue by Application (2025-2030) & (US$ Million)
Figure 62. MEALA Breast-Conserving Surgery Revenue Share by Application (2019-2030)
Figure 63. MEALA Breast-Conserving Surgery Revenue Share by Country (2019-2030)
Figure 64. Mexico Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 65. South Korea Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. Brazil Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Israel Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Argentina Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Colombia Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Turkey Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Saudi Arabia Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. UAE Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Years Considered
Figure 74. Research Process
Figure 75. Key Executives Interviewed
